Finnrick, an independent testing programme, publishes 16 assays for Qianmiao Peptide: 14 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 15 Jul 2026.
Qianmiao Peptide listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/qianmiao-peptide.
Qianmiao Peptide sells to businesses rather than direct to researchers and operates from Hong Kong. The site says it has traded since 2013. It lists 44 products, including AOD-9604, ARA-290 (Cibinetide), BPC-157, BPC-157 + TB-500, Cagrilintide, and CAGRILINTIDE + SEMAGLUTIDE, plus 29 other compounds. It also produces and labels to order, so stock sold under other brand names may come from here.
In its own words: “Research-focused peptide production and B2B supply — built on in-house synthesis, disciplined quality control and dependable global fulfillment for laboratories, distributors and sourcing partners.”
Qianmiao Peptide publishes 70 certificates of analysis on its site. The vendor chose which batches to publish, so those results do not tell you what is in the vial you receive. Of the 12 product pages we opened, 11 state 99% purity.
No prices are published. You have to ask over messaging before you can compare cost against another supplier.
Site check: 44 products listed; 70 certificates of analysis published; operates from Hong Kong.
Qianmiao Peptide is listed as active. Finnrick Grade C. Finnrick avg score: 7/10 across 6 samples (1 products). Mixed quality — some products test well, others below average.
Qianmiao Peptide holds independent lab grade C, assigned across 6 graded samples, average score 7/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
Community standing: 3.5/5 on Trustpilot from 27 reviews. Ratings of anonymous sellers of unregulated products are the weakest signal on this page; the assay and grading records carry more.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 11 | 9 passed, 2 failed |
| Tirzepatide | 5 | 5 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | C (6 samples) |
| Average grader score | 7/10 |
| Trustpilot | 3.5/5 from 27 reviews |
| Vendor type | Research-use supplier |
These details were read from Qianmiao Peptide's own website on 2026-08-10. Pages consulted:
Qianmiao Peptide is listed as active and we hold 16 Finnrick assays (14 passing, 2 failing its purity threshold); 70 certificates of analysis published on its own site; an independent lab grade of C. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 16 assays for Qianmiao Peptide: 14 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 2 did not. Most recent assay 15 Jul 2026.
Qianmiao Peptide ships from Hong Kong.
Similar vendors: Peptide Sciences, Limitless Life Nootropics, Polaris Peptides, NextechLabs, Yiwu Aozuo Trading Co, Shandong Shengyuan Peptide Technology, Bulk Peptide Supply, Skye Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Qing Li Peptide Review, Qingdao Changlion Peptides Review, Qingdao Hongshengda Trading Peptides Review.